Literature DB >> 33255900

Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF).

Philip Storck1, Florian Umstätter1, Sabrina Wohlfart1, Cornelius Domhan2, Christian Kleist1, Julia Werner1, Klaus Brandenburg3, Stefan Zimmermann4, Uwe Haberkorn1, Walter Mier1, Philipp Uhl1.   

Abstract

The increasing number of infections caused by multidrug-resistant bacteria requires an intensified search for new antibiotics. Pep19-4LF is a synthetic antimicrobial peptide (GKKYRRFRWKFKGKLFLFG) that was previously designed with the main focus on high antimicrobial activity. The hydrophobic motif, LFLFG, was found to be essential for antimicrobial activity. However, this motif shows several limitations such as aggregation in biological media, low solubility, and small yields in peptide synthesis. In order to obtain more appropriate peptide characteristics, the hydrophobic motif was replaced with fatty acids. For this purpose, a shortened variant of Pep19-4LF (Pep19-short; GKKYRRFRWKFKGK) was synthesized and covalently linked to saturated fatty acids of different chain lengths. The peptide conjugates were tested with respect to their antibacterial activity by microdilution experiments on different bacterial strains. The length of the fatty acid was found to be directly correlated to the antimicrobial activity up to an ideal chain length (undecanoic acid, C11:0). This conjugate showed high antimicrobial activity in absence of toxicity. Time-kill studies revealed a fast and bactericidal mode of action. Furthermore, the first in vivo experiments of the conjugate in rodents demonstrated pharmacokinetics appropriate for application as a drug. These results clearly indicate that the hydrophobic motif of the peptide can be replaced by a single fatty acid of medium length, simplifying the design of this antimicrobial peptide while retaining high antimicrobial activity in the absence of toxicity.

Entities:  

Keywords:  Enterococcus faecium; Staphylococcus aureus; antimicrobial activity; fatty acid conjugation; synthetic antimicrobial peptides

Year:  2020        PMID: 33255900      PMCID: PMC7760514          DOI: 10.3390/antibiotics9120844

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  26 in total

1.  The effect of lipidation and glycosylation on short cationic antimicrobial peptides.

Authors:  Elizabeth Grimsey; Dominic W P Collis; Ralf Mikut; Kai Hilpert
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-03-01       Impact factor: 3.747

2.  Antimicrobial peptides Pep19-2.5 and Pep19-4LF inhibit Streptococcus mutans growth and biofilm formation.

Authors:  Hanen Jannadi; Wilmar Correa; Ze Zhang; Klaus Brandenburg; Ridha Oueslati; Mahmoud Rouabhia
Journal:  Microb Pathog       Date:  2019-05-18       Impact factor: 3.738

3.  Peptide drug stability: The anti-inflammatory drugs Pep19-2.5 and Pep19-4LF in cream formulation.

Authors:  Nicole Kuhlmann; Lena Heinbockel; Wilmar Correa; Thomas Gutsmann; Torsten Goldmann; Uwe Englisch; Klaus Brandenburg
Journal:  Eur J Pharm Sci       Date:  2018-01-12       Impact factor: 4.384

4.  Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides.

Authors:  Yani Kaconis; Ina Kowalski; Jörg Howe; Annemarie Brauser; Walter Richter; Iosu Razquin-Olazarán; Melania Iñigo-Pestaña; Patrick Garidel; Manfred Rössle; Guillermo Martinez de Tejada; Thomas Gutsmann; Klaus Brandenburg
Journal:  Biophys J       Date:  2011-06-08       Impact factor: 4.033

5.  New antiseptic peptides to protect against endotoxin-mediated shock.

Authors:  Thomas Gutsmann; Iosu Razquin-Olazarán; Ina Kowalski; Yani Kaconis; Jörg Howe; Rainer Bartels; Mathias Hornef; Tobias Schürholz; Manfred Rössle; Susana Sanchez-Gómez; Ignacio Moriyon; Guillermo Martinez de Tejada; Klaus Brandenburg
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

6.  Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori.

Authors:  Cynthia Q Sun; Charmian J O'Connor; Anthony M Roberton
Journal:  FEMS Immunol Med Microbiol       Date:  2003-05-15

Review 7.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.

Authors:  Cornelius Domhan; Philipp Uhl; Anna Meinhardt; Stefan Zimmermann; Christian Kleist; Thomas Lindner; Karin Leotta; Walter Mier; Michael Wink
Journal:  Int J Antimicrob Agents       Date:  2018-04-09       Impact factor: 5.283

Review 9.  Dalbavancin: a novel antimicrobial.

Authors:  A Y Chen; M J Zervos; J A Vazquez
Journal:  Int J Clin Pract       Date:  2007-03-16       Impact factor: 2.503

10.  Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration.

Authors:  Anja Pfalzgraff; Lena Heinbockel; Qi Su; Thomas Gutsmann; Klaus Brandenburg; Günther Weindl
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

View more
  3 in total

1.  Development of Effective Antibacterial Treatment: Lessons from the Past and Novel Approaches.

Authors:  Mariagrazia Di Luca; Tiziano Marzo
Journal:  Antibiotics (Basel)       Date:  2021-02-25

2.  C-Locked Analogs of the Antimicrobial Peptide BP214.

Authors:  Ida Kristine Lysgaard Andersen; Thomas T Thomsen; Jasmina Rashid; Thomas Rønnemoes Bobak; Alberto Oddo; Henrik Franzyk; Anders Løbner-Olesen; Paul R Hansen
Journal:  Antibiotics (Basel)       Date:  2022-08-09

3.  Effects of Lysine N-ζ-Methylation in Ultrashort Tetrabasic Lipopeptides (UTBLPs) on the Potentiation of Rifampicin, Novobiocin, and Niclosamide in Gram-Negative Bacteria.

Authors:  Linus Schweizer; Danyel Ramirez; Frank Schweizer
Journal:  Antibiotics (Basel)       Date:  2022-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.